Skip to main content

Management of Ocular Surface Allergic Diseases

  • Chapter
  • First Online:
Ocular Surface Disease
  • 879 Accesses

Abstract

Allergic eye disease encompasses a spectrum of distinct but overlapping conditions. It includes acute seasonal allergic conjunctivitis (SAC), as well as the chronic conditions of perennial allergic conjunctivitis (PAC), atopic keratoconjunctivitis (AKC), and vernal keratoconjunctivitis (VKC). All the allergic eye diseases involve IgE-mediated type I hypersensitivity, leading to varying degrees of itching, redness, and tearing as common ocular surface symptoms in these patients. However, AKC and VKC are distinct from seasonal and perennial allergic disease in that the immune mechanisms in AKC and VKC are much more complex. In both conditions, a T-cell-mediated type IV hypersensitivity response, as well as activation of other inflammatory cytokine pathways, leads to more severe and prolonged conjunctival inflammation, as well as corneal involvement (Foster et al. Ophthalmology 1991;98(8):1190–1196). Here we will discuss several cases of allergic eye disease, including their diagnosis and management, with emphasis on distinguishing among the different types of allergic eye diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tsubota K, Takamura E, Hasegawa T, Kobayashi T. Detection by brush cytology of mast cells and eosinophils in allergic and vernal conjunctivitis. Cornea. 1991;10(6):525–31.

    Article  CAS  PubMed  Google Scholar 

  2. Montan PG, van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol. 1996;80(6):556–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Inada N, Shoji J, Kato H, Kiely S, Mulyanto SM. Clinical evaluation of total IgE in tears of patients with allergic conjunctivitis disease using a novel application of the immunochromatography method. Allergol Int. 2009;58(4):585–9. doi:10.2332/allergolint.09-OA-0101.

    Article  CAS  PubMed  Google Scholar 

  4. Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow up. Ophthalmology. 2000;107(6):1157–63. doi: S0161-6420(00)00092-0 [pii]

    Article  CAS  PubMed  Google Scholar 

  5. Pattnaik L, Acharya LA. comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics. Life Sci. 2015;128:47–54. doi:10.1016/j.lfs.2015.01.040.

    Article  CAS  PubMed  Google Scholar 

  6. Bonini S, Lambiase A, Sgrulletta R, Bonini S. Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2003;3(5):381–7. doi:10.1097/01.all.0000092610.76804.8a.

    Article  PubMed  Google Scholar 

  7. Donshik PC. Allergic conjunctivitis. Int Ophthalmol Clin. 1988;28(4):294–302.

    Article  CAS  PubMed  Google Scholar 

  8. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ. Clinical features of atopic keratoconjunctivitis. Ophthalmology. 1991;98(2):150–8.

    Article  CAS  PubMed  Google Scholar 

  9. Lambiase A, Bonini S, Rasi G, Coassin M, Bruscolini A, Bonini S. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma. Arch Ophthalmol. 2003;121(5):615–20. doi:10.1001/archopht.121.5.615.

    Article  CAS  PubMed  Google Scholar 

  10. Gane J, Buckley R. Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2013;1(1):65–74. doi:10.1016/j.jaip.2012.07.001.

    Article  PubMed  Google Scholar 

  11. Neumann E, Gutmann MJ, Blumenkrantz N, Michaelson IC. A review of four hundred cases of vernal conjunctivitis. Am J Ophthalmol. 1959;47(2):166–72.

    Article  CAS  PubMed  Google Scholar 

  12. Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology. 1995;102(6):985–93.

    Article  CAS  PubMed  Google Scholar 

  13. Cameron JA, Antonios SR, Badr IA. Excimer laser phototherapeutic keratectomy for shield ulcers and corneal plaques in vernal keratoconjunctivitis. J Refract Surg. 1995;11(1):31–5.

    CAS  PubMed  Google Scholar 

  14. Holsclaw DS, Whitcher JP, Wong IG, Margolis TP. Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol. 1996;121(3):243–9.

    Article  CAS  PubMed  Google Scholar 

  15. Saini JS, Gupta A, Pandey SK, Gupta V, Gupta P. Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis. Acta Ophthalmol Scand. 1999;77(5):515–8.

    Article  CAS  PubMed  Google Scholar 

  16. Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am. 2010;30(3):323–36. doi:10.1016/j.iac.2010.06.004.

    Article  PubMed  Google Scholar 

  17. Bremond-Gignac D, Nischal KK, Mortemousque B, Gajdosova E, Granet DB, Chiambaretta F. Atopic keratoconjunctivitis in children: clinical features and diagnosis. Ophthalmology. 2015;123(2):435–7. doi: S0161-6420(15)00703-4 [pii]

    Article  PubMed  Google Scholar 

  18. Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology. 1998;105(4):637–42. doi: S0161-6420(98)94017-9 [pii]

    Article  CAS  PubMed  Google Scholar 

  19. Hogan MJ. Atopic keratoconjunctivitis. Am J Ophthalmol. 1953;36(7 1):937–47.

    Article  CAS  PubMed  Google Scholar 

  20. Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2010;10(5):478–85. doi:10.1097/ACI.0b013e32833e16e4.

    Article  CAS  PubMed  Google Scholar 

  21. Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol. 2014;70(3):569–75. doi:10.1016/j.jaad.2013.10.036.

    Article  PubMed  Google Scholar 

  22. Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology. 1990;97(8):992–1000.

    Article  CAS  PubMed  Google Scholar 

  23. Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol. 2000;84(8):834–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Rahi A, Davies P, Ruben M, Lobascher D, Menon J. Keratoconus and coexisting atopic disease. Br J Ophthalmol. 1977;61(12):761–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Harrison RJ, Klouda PT, Easty DL, Manku M, Charles J, Stewart CM. Association between keratoconus and atopy. Br J Ophthalmol. 1989;73(10):816–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Yoneda K, Okamoto H, Wada Y, et al. Atopic retinal detachment. Report of four cases and a review of the literature. Br J Dermatol. 1995;133(4):586–91.

    Article  CAS  PubMed  Google Scholar 

  27. Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2010;24(3):317–28. doi:10.1111/j.1468-3083.2009.03415.x.

    Article  CAS  PubMed  Google Scholar 

  28. Attas-Fox L, Barkana Y, Iskhakov V, et al. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study. Curr Eye Res. 2008;33(7):545–9. doi:10.1080/02713680802149115.

    Article  CAS  PubMed  Google Scholar 

  29. Rikkers SM, Holland GN, Drayton GE, Michel FK, Torres MF, Takahashi S. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol. 2003;135(3):297–302. doi: S0002939402019827 [pii]

    Article  CAS  PubMed  Google Scholar 

  30. Akpek EK, Dart JK, Watson S, et al. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology. 2004;111(3):476–82. doi:10.1016/j.ophtha.2003.05.035.

    Article  PubMed  Google Scholar 

  31. Daniell M, Constantinou M, Vu HT, Taylor HR. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol. 2006;90(4):461–4. doi: 90/4/461 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol. 2011;11(5):477–82. doi:10.1097/ACI.0b013e32834a9652.

    Article  CAS  PubMed  Google Scholar 

  33. Taille C, Doan S, Neukirch C, Aubier M. Omalizumab for severe atopic keratoconjunctivitis. BMJ Case Rep. 2010;2010:pii: bcr0420102919. doi:10.1136/bcr.04.2010.2919.

    Article  Google Scholar 

  34. Daniell MD, Dart JK, Lightman S. Use of cyclosporin in the treatment of steroid resistant post-keratoplasty atopic sclerokeratitis. Br J Ophthalmol. 2001;85(1):91–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Priti Batta MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Paik, J., Batta, P. (2018). Management of Ocular Surface Allergic Diseases. In: Djalilian, A. (eds) Ocular Surface Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-15823-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15823-5_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15822-8

  • Online ISBN: 978-3-319-15823-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics